GOP Presses RFK Jr on Mifepristone Review
No Priors AI
00:00
Potential Impact on Access and Costs
Jeremy explains how stricter dispensing, telehealth rollbacks, and stopping generics could limit access and raise costs.
Play episode from 02:19
Transcript
